6533b831fe1ef96bd1298e1e
RESEARCH PRODUCT
Itinéraire d’un agent double
Véronique LaurensSabrina RomagnyStéphanie PlenchetteAli Bettaiebsubject
0301 basic medicineProgrammed cell deathMechanism (biology)Cell growthGeneral MedicineBiologyGeneral Biochemistry Genetics and Molecular Biology3. Good healthNo donorsCellular mechanism03 medical and health sciences030104 developmental biology0302 clinical medicine030220 oncology & carcinogenesisCytotoxic T cellTumor growthSignal transductionNeurosciencedescription
Protein S-nitrosylation is now recognized as a ubiquitous regulatory mechanism. Like any post-translational modifications, S-nitrosylation is critical for the control of numerous cellular processes. It is now clear that S-nitrosylation is playing a double game, enhancing or inhibiting the tumor growth or the induction of cell death. Thanks to research aimed at demonstrating NO cytotoxic effects, new therapeutic strategies based on NO donor drugs have emerged. Although therapeutic NO donors can target a large number of proteins, the cellular mechanism is still not fully understood. This review reflects the current state of knowledge on S-nitrosylated proteins that take part of the oncogenic and apoptotic signaling, putting forward proteins with potential interest in cancer therapy.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2016-06-01 | médecine/sciences |